drugset / Trial / NCT05003765
Are Superficial Parasternal Intercostal Plane (SPIP) Blocks With Bupivacaine and With or Without Adjuvants Helpful for Post-operative Pain After Coronary Artery Bypass Grafting?
RandomizedParallel-groupTriple-blindSupportive care
Summary
The purpose of this study is to determine whether the addition of the superficial parasternal intercostal plane (SPIP) block alone (30cc of 0.25% bupivacaine) or plus Magnesium (200mg of magnesium sulfate) or plus Magnesium + Buprenorphine (300mcg) as adjuvants can improve post-operative pain in patients undergoing cardiothoracic surgery, specifically, coronary artery bypass grafting (CABG)
Timeline
- Start
- 2020-08-06
- Primary completion
- 2022-05-01
- Completion
- 2022-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |
| Subject | Buprenorphine | Other / unclassified | 300 ug | Other |
| Subject | Magnesium Sulfate | Other / unclassified | 200 mg | Other |
Indications
No indication recorded.